Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-11-04
DOI
10.1038/srep16103
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma
- (2015) Cheng Wang et al. Scientific Reports
- Upregulated miR-106a plays an oncogenic role in pancreatic cancer
- (2014) Pei Li et al. FEBS LETTERS
- Cholangiocarcinoma
- (2014) Nataliya Razumilava et al. LANCET
- Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma
- (2014) Feng Zhi et al. NEURO-ONCOLOGY
- Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2
- (2014) Z Wang et al. ONCOGENE
- Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer
- (2014) Allen S. Ho et al. Translational Oncology
- Upregulated expression of miR-106a by DNA hypomethylation plays an oncogenic role in hepatocellular carcinoma
- (2014) Renshun Yuan et al. TUMOR BIOLOGY
- Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
- (2013) J H Huh et al. BRITISH JOURNAL OF CANCER
- Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer
- (2013) Long Cui et al. CANCER
- Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer
- (2013) Tomoya Kishimoto et al. CANCER SCIENCE
- The Prognostic Value of MicroRNAs Varies with Patient Race/Ethnicity and Stage of Colorectal Cancer
- (2013) L. C. Bovell et al. CLINICAL CANCER RESEARCH
- Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment
- (2013) J.B. Kjersem et al. Molecular Oncology
- MiR-106a is an independent prognostic marker in patients with glioblastoma
- (2013) Shiguang Zhao et al. NEURO-ONCOLOGY
- Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis
- (2013) Xiaoqing Jiang et al. OncoTargets and Therapy
- MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis
- (2012) Kai Wang et al. CARCINOGENESIS
- Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV
- (2012) Q.-B. Cheng et al. EJSO
- miR-106a overexpression and pRB downregulation in sporadic colorectal cancer
- (2012) T. Catela Ivkovic et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma
- (2012) Baek-Hui Kim et al. JOURNAL OF SURGICAL ONCOLOGY
- Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer
- (2012) P. Tucci et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer
- (2011) D. Li et al. CLINICAL CANCER RESEARCH
- MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status
- (2011) Guang Yang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
- (2011) Peng Qi et al. PLoS One
- Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
- (2010) Helen M. Heneghan et al. ANNALS OF SURGERY
- Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
- (2010) Jian Xu et al. MOLECULAR CARCINOGENESIS
- Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
- (2009) E K O Ng et al. GUT
- Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells
- (2009) Junfang Ji et al. HEPATOLOGY
- MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3
- (2009) Florin M. Selaru et al. HEPATOLOGY
- Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
- (2009) Zhaohui Huang et al. INTERNATIONAL JOURNAL OF CANCER
- Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters
- (2008) Andrea Ventura et al. CELL
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
- The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
- (2008) Kimberly E. Resnick et al. GYNECOLOGIC ONCOLOGY
- Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment
- (2008) Boris Blechacz et al. HEPATOLOGY
- The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma
- (2008) Lei Chen et al. JOURNAL OF HEPATOLOGY
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
- (2008) Johan Skog et al. NATURE CELL BIOLOGY
- Serum-based microRNAs: Are we blinded by potential?
- (2008) D. B. Jackson PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started